Dopaminergic therapy and subthalamic stimulation in Parkinson's disease: A review of 5-year reports

Journal of Neurology

Volumn 257, Issue SUPPL. 2, 2010, Pages

  Romito, Luigi M ^a   Albanese, Alberto ^a  

^a UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

DBS; Deep brain stimulation; Levodopa; Parkinson's disease; Subthalamus; Surgery

Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

APATHY; APRAXIA; BODY POSTURE; BRAIN DEPTH STIMULATION; COGNITIVE DEFECT; CONFERENCE PAPER; CONFUSION; DELIRIUM; DEPRESSION; DEVICE INFECTION; DISEASE COURSE; DISEASE DURATION; DYSARTHRIA; DYSKINESIA; DYSPHAGIA; DYSTONIA; EYELID OPENING APRAXIA; FOLLOW UP; HUMAN; HYPOMANIA; MEDICAL LITERATURE; MENTAL INSTABILITY; MOTOR DYSFUNCTION; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; PSYCHOSIS; SPEECH; SUBTHALAMIC NUCLEUS; SYSTEMATIC REVIEW; THERAPY EFFECT; UNIFIED PARKINSON DISEASE RATING SCALE; WEIGHT GAIN; ELECTRODE; INSTRUMENTATION; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STANDARD;

DEEP BRAIN STIMULATION; DOPAMINE AGENTS; ELECTRODES, IMPLANTED; HUMANS; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS;

EID: 79957489830     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5720-3     Document Type: Conference Paper

References (38)

1. Agid Y, Arnulf I, Bejjani P, Bloch F, Bonnet AM, Damier P, Dubois B, Francois C, Houeto JL, Iacono D, Karachi C, Mesnage V, Messouak O, Vidailhet M, Welter ML, Yelnik J (2003) Parkinson's disease is a neuropsychiatric disorder. Adv Neurol 91:365-370
2. Bechtereva NP, Hughes HK (1971) Implanted electrodes: experimentation on humans? Am J Psychiatry 127:1422-1423
3. Bejjani BP, Arnulf I, Demeret S, Damier P, Bonnet AM, Houeto JL, Agid Y (2000) Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible? Ann Neurol 47:655-658 (Pubitemid 30261904)
4. Benabid AL, Chabardes S, Mitrofanis J, Pollak P (2009) Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 8:67-81
5. Benabid AL, Pollak P, Gross C, Hoffmann D, Benazzouz A, Gao DM, Laurent A, Gentil M, Perret J (1994) Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg 62:76-84
6. Benabid AL, Pollak P, Louveau A, Henry S, de RJ (1987) Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 50:344-346 (Pubitemid 18043161)
7. Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y (1987) Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology 37:1539-1542 (Pubitemid 17137644)
8. Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464-474
9. Contarino MF, Daniele A, Sibilia AH, Romito LM, Bentivoglio AR, Gainotti G, Albanese A (2007) Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 78:248-252 (Pubitemid 46579660)
10. Defer GL, Widner H, Marie RM, Remy P, Levivier M (1999) Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 14:572-584 (Pubitemid 30011449)
11. Funkiewiez A, Ardouin C, Caputo E, Krack P, Fraix V, Klinger H, Chabardes S, Foote K, Benabid AL, Pollak P (2004) Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 75:834-839 (Pubitemid 38658504)
12. Gervais-Bernard H, Xie-Brustolin J, Mertens P, Polo G, Klinger H, Adamec D, Broussolle E, Thobois S (2009) Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up. J Neurol 256:225-233
13. Herzog J, Pinsker M, Wasner M, Steigerwald F, Wailke S, Deuschl G, Volkmann J (2007) Stimulation of subthalamic fibre tracts reduces dyskinesias in STN-DBS. Mov Disord 22:679-684 (Pubitemid 46800138)
14. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184
15. Katayama Y, Oshima H, Kano T, Kobayashi K, Fukaya C, Yamamoto T (2006) Direct effect of subthalamic nucleus stimulation on levodopa-induced peak-dose dyskinesia in patients with Parkinson's disease. Stereotact Funct Neurosurg 84:176-179 (Pubitemid 44359559)
16. Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE (2003) Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 99:489-495 (Pubitemid 37040409)
17. Krack P, Batir A, Van BN, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, Lebas JF, Benabid AL, Pollak P (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 349:1925-1934 (Pubitemid 37409709)
18. Le JF, Drapier D, Bourguignon A, Peron J, Mesbah H, Drapier S, Sauleau P, Haegelen C, Travers D, Garin E, Malbert CH, Millet B, Verin M (2009) Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology 73:1746-1751
19. Lees AJ, Hardy J, Revesz T (2009) Parkinson's disease. Lancet 373:2055-2066
20. Limousin P, Martinez-Torres I (2008) Deep brain stimulation for Parkinson's disease. Neurotherapeutics 5:309-319 (Pubitemid 351446211)
21. Maetzler W, Liepelt I, Berg D (2009) Progression of Parkinson's disease in the clinical phase: potential markers. Lancet Neurol 8:1158-1171
22. Oueslati A, Sgambato-Faure V, Melon C, Kachidian P, Gubellini P, Amri M, Kerkerian-Le GL, Salin P (2007) High-frequency stimulation of the subthalamic nucleus potentiates L-DOPAinduced neurochemical changes in the striatum in a rat model of Parkinson's disease. J Neurosci 27:2377-2386 (Pubitemid 46340976)
23. Pahwa R, Wilkinson SB, Overman J, Lyons KE (2003) Bilateral subthalamic stimulation in patients with Parkinson disease: longterm follow up. J Neurosurg 99:71-77 (Pubitemid 36753879)
24. Piboolnurak P, Lang AE, Lozano AM, Miyasaki JM, Saint-Cyr JA, Poon YY, Hutchison WD, Dostrovsky JO, Moro E (2007) Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease. Mov Disord 22:990-997 (Pubitemid 46999296)
25. Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van BN (2005) Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 128:2240-2249 (Pubitemid 41407964)
26. Romito LM, Contarino MF, Vanacore N, Bentivoglio AR, Scerrati M, Albanese A (2008) Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation. Mov Disord 24:555-561
27. Romito LM, Contarino MF, Vanacore N, Bentivoglio AR, Scerrati M, Albanese A (2009) Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation. Mov Disord 24:557-563
28. Romito LM, Scerrati M, Contarino MF, Bentivoglio AR, Tonali P, Albanese A (2002) Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology 58:1546-1550 (Pubitemid 34552968)
29. Schupbach WM, Chastan N, Welter ML, Houeto JL, Mesnage V, Bonnet AM, Czernecki V, Maltete D, Hartmann A, Mallet L, Pidoux B, Dormont D, Navarro S, Cornu P, Mallet A, Agid Y (2005) Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 76:1640-1644 (Pubitemid 41697626)
30. Siegfried J, Lippitz B (1994) Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 35:1126-1129
31. Simonin C, Tir M, Devos D, Kreisler A, Dujardin K, Salleron J, Delval A, Blond S, Defebvre L, Destee A, Krystkowiak P (2009) Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon. J Neurol 256:1736-1741
32. Stocchi F, Tagliati M, Olanow CW (2008) Treatment of levodopa- induced motor complications. Mov Disord 23(Suppl 3):S599-S612
33. Visser-Vandewalle V, van der LC, Temel Y, Celik H, Ackermans L, Spincemaille G, Caemaert J (2005) Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up study. Parkinsonism Relat Disord 11:157-165
34. Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N, Juncos JL, Obeso JA, Bezard E (2009) Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol 8:1140-1149
35. Wallace BA, Ashkan K, Heise CE, Foote KD, Torres N, Mitrofanis J, Benabid AL (2007) Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain 130:2129-2145 (Pubitemid 47236623)
36. Warnke PC (2005) STN stimulation and neuroprotection in Parkinson's disease-when beautiful theories meet ugly facts. J Neurol Neurosurg Psychiatry 76:1186-1187
37. Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ (2007) Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord 14:114-119
38. Zibetti M, Pesare M, Cinquepalmi A, Rosso M, Bergamasco B, Ducati A, Lanotte M, Lopiano L (2008) Antiparkinsonian therapy modifications in PD patients after STN DBS: a retrospective observational analysis. Parkinsonism Relat Disord 14:608-612